1. Home
  2. GILT vs BCRX Comparison

GILT vs BCRX Comparison

Compare GILT & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gilat Satellite Networks Ltd.

GILT

Gilat Satellite Networks Ltd.

HOLD

Current Price

$16.07

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$8.47

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GILT
BCRX
Founded
1987
1986
Country
Israel
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.6B
IPO Year
1997
1995

Fundamental Metrics

Financial Performance
Metric
GILT
BCRX
Price
$16.07
$8.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
11
Target Price
$20.00
$20.82
AVG Volume (30 Days)
1.1M
4.0M
Earning Date
01-01-0001
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
381.40
EPS
N/A
1.21
Revenue
N/A
$25,186,000.00
Revenue This Year
$15.06
N/A
Revenue Next Year
$11.72
$12.55
P/E Ratio
$42.82
$7.00
Revenue Growth
N/A
N/A
52 Week Low
$5.30
$6.00
52 Week High
$20.38
$11.31

Technical Indicators

Market Signals
Indicator
GILT
BCRX
Relative Strength Index (RSI) 49.50 69.72
Support Level $13.11 $7.95
Resistance Level $20.38 $8.68
Average True Range (ATR) 0.83 0.33
MACD 0.15 0.12
Stochastic Oscillator 59.91 81.19

Price Performance

Historical Comparison
GILT
BCRX

About GILT Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: